News Daily News Even With Optimized GDMT, HFrEF Prognosis Remains Dire Michael O'Riordan January 30, 2026
News Daily News Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators Michael O'Riordan January 22, 2026
News Daily News Weight Regained Within 18 Months of Stopping GLP-1 Drugs Michael O'Riordan January 08, 2026
News Daily News Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure Michael O'Riordan December 30, 2025
News Daily News SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide Michael O'Riordan December 18, 2025
News Daily News Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER Michael O'Riordan December 12, 2025
News Daily News Making Sense of Masters Athletes’ Cardiac Imaging: Expert Review Michael O'Riordan December 11, 2025
News Daily News Frail Patients Stand to Gain Most From Cardiac Rehab Michael O'Riordan November 26, 2025
News Daily News Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE Michael O'Riordan November 24, 2025
News Daily News Risk Calculators Miss Many Patients Who Present With First MI Michael O'Riordan November 21, 2025
News Daily News High Adolescent BP Tied to Subclinical Disease in Middle Age Michael O'Riordan November 20, 2025
News Daily News A Little Exercise, No Matter When It’s Done, Benefits Older Women Michael O'Riordan October 24, 2025
News Daily News High Aerobic Fitness Linked to Less Chronic Disease in Later Life Michael O'Riordan October 10, 2025
News Daily News Risk Factors Present in Nearly All Patients Who Develop CVD Michael O'Riordan October 02, 2025
News Daily News CVD Still the Leading Cause of Death and Disease Globally Michael O'Riordan September 24, 2025
News Daily News Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s Michael O'Riordan September 18, 2025
News Daily News Evolocumab Gains Expanded Indication for Primary Prevention Michael O'Riordan August 26, 2025